ADRA2B anticorps (Center, Internal Region)
Aperçu rapide pour ADRA2B anticorps (Center, Internal Region) (ABIN2196821)
Antigène
Voir toutes ADRA2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Center, Internal Region
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- ADRA2B, ID (Alpha-2B Adrenergic Receptor, Alpha-2B Adrenoreceptor, Alpha-2B Adrenoceptor, Alpha-2BAR, Alpha-2 Adrenergic Receptor Subtype C2, ADRA2L1, ADRA2RL1)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide selected from the Center region of human ADRA2B (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Autre désignation
- ADRA2B
-
NCBI Accession
- NP_000673
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Antigène
-